Back to discover
Disease

Prion Diseases

Emerging researchSteady momentum
6
Publications
1
Related conditions
3
Related proteins
2025
Latest publication
Current focus
Prion biologyPrions biologyGenetics & risk factorsDisease mechanisms & pathology
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

No activity recorded in this window. Try a wider timeframe.

Research activity

6 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20012025
Most influential

Shattuck lecture--neurodegenerative diseases and prions.

The New England journal of medicine · 2001 · 464 cites

Prions.

Cold Spring Harbor perspectives in biology · 2011 · 376 cites

Wildlife as source of zoonotic infections.

Emerging infectious diseases · 2004 · 217 cites
Recent publications

Prions.

Cold Spring Harbor perspectives in biology · 2011 · 376 cites

Wildlife as source of zoonotic infections.

Emerging infectious diseases · 2004 · 217 cites

Shattuck lecture--neurodegenerative diseases and prions.

The New England journal of medicine · 2001 · 464 cites
Major themes8
  • Prion Diseases3
  • Disease Reservoirs1
  • Encephalopathy, Bovine Spongiform1
  • Gene Editing1
  • Genetic Variation1
  • Longevity1
  • Models, Molecular1
  • Neurodegenerative Diseases1
Leading journals6
  • BMB reports1
  • Cold Spring Harbor perspectives in biology1
  • Emerging infectious diseases1
  • Experimental & molecular medicine1
  • Nature medicine1
  • The New England journal of medicine1
Leading researchers8
  • Prusiner SB2
  • An M1
  • Berríos KN1
  • Brauer PP1
  • Cha S1
  • Ciechanover A1
  • Coffey AA1
  • Colby DW1
Affiliations (unnormalised)6
  • 1] Protein Metabolism Medical Research Center and Department of Biomedical Sciences1
  • Broad Institute of MIT and Harvard1
  • Case Western Reserve University1
  • Harvard Medical School1
  • Harvard University1
  • Howard Hughes Medical Institute1

Disease biology

3 matches

Key proteins & gene products studied in this disease. Number shows shared papers.

Related conditions

1 match

Diseases frequently studied alongside this one. Number shows shared papers.

Disease profile

A grounded synthesis of the condition — overview, causes, mechanism, risk factors and current standard of care.

Overview

Prion diseases are a group of genetic, infectious, or sporadic degenerative disorders of the nervous system in humans and animals that are associated with abnormal prions. They are characterized by conversion of the normal prion protein into an abnormal configuration through a post-translational process. In humans, they generally present with dementia and ataxia and are typically fatal, with spongiform encephalopathy on pathology and no evidence of inflammation.

Causes

The grounding supports three broad aetiologic categories: genetic, infectious, and sporadic forms. Overwhelming evidence indicates that Creutzfeldt-Jakob disease and related disorders are caused by prions, which can transmit disease by recruiting normal cellular prion protein into the disease-associated isoform. The literature also notes older descriptions of these disorders as unconventional slow virus diseases.

Pathophysiology

Prion diseases arise when the normal cellular prion protein (PrP(C)) is converted into the abnormal disease-associated isoform (PrP(Sc)). PrP(Sc) can template further conversion of PrP(C), allowing propagation of the misfolded state. This process is associated with neurodegeneration, lethality, and spongiform encephalopathy without inflammation.

Risk factors

The grounding supports infectious exposure, genetic susceptibility, and sporadic occurrence as broad risk categories. Transmission is a recognized aspect of the literature, and wildlife reservoirs are noted as relevant for zoonotic infections in general. No more specific risk factors are supported by the supplied material.

Current standard of care

The supplied grounding does not support a specific standard treatment regimen or drug class for prion diseases. The literature provided emphasizes diagnosis, prevention and control, transmission, and the biology of misfolded prion protein rather than a defined therapeutic standard. One review discusses general strategies for degrading misfolded proteins, including proteasome, chaperone-mediated autophagy, and macroautophagy, but this is not presented as established care for prion disease.

AI-generated summary grounded in MeSH and 4 peer-reviewed sources. Informational only — not medical advice. Generated 2026-07-07.

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

A group of genetic, infectious, or sporadic degenerative human and animal nervous system disorders associated with abnormal PRIONS. These diseases are characterized by conversion of the normal prion protein to an abnormal configuration via a post-translational process. In humans, these conditions generally feature DEMENTIA; ATAXIA; and a fatal outcome. Pathologic features include a spongiform encephalopathy without evidence of inflammation. The older literature occasionally refers to these as unconventional SLOW VIRUS DISEASES. (From Proc Natl Acad Sci USA 1998 Nov 10;95(23):13363-83)

References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.